DK1091774T3 - Knoglecement med antimikrobielle peptider - Google Patents

Knoglecement med antimikrobielle peptider

Info

Publication number
DK1091774T3
DK1091774T3 DK99931589T DK99931589T DK1091774T3 DK 1091774 T3 DK1091774 T3 DK 1091774T3 DK 99931589 T DK99931589 T DK 99931589T DK 99931589 T DK99931589 T DK 99931589T DK 1091774 T3 DK1091774 T3 DK 1091774T3
Authority
DK
Denmark
Prior art keywords
bone cement
amino acids
amps
bone
domain
Prior art date
Application number
DK99931589T
Other languages
Danish (da)
English (en)
Inventor
Elisabeth Henritte Burger
Nieuw Amerongen Arie Van
Paulus Ignatius Jozef Wuisman
Original Assignee
Stichting Skeletal Tissue Engi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stichting Skeletal Tissue Engi filed Critical Stichting Skeletal Tissue Engi
Application granted granted Critical
Publication of DK1091774T3 publication Critical patent/DK1091774T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/02—Inorganic materials
    • A61L27/12—Phosphorus-containing materials, e.g. apatite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/02—Surgical adhesives or cements; Adhesives for colostomy devices containing inorganic materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/10—Polypeptides; Proteins
    • A61L24/106—Fibrin; Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/227—Other specific proteins or polypeptides not covered by A61L27/222, A61L27/225 or A61L27/24
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2310/00—Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
    • A61F2310/00005—The prosthesis being constructed from a particular material
    • A61F2310/00179—Ceramics or ceramic-like structures
    • A61F2310/00293—Ceramics or ceramic-like structures containing a phosphorus-containing compound, e.g. apatite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/25—Peptides having up to 20 amino acids in a defined sequence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/02—Materials or treatment for tissue regeneration for reconstruction of bones; weight-bearing implants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Materials For Medical Uses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK99931589T 1998-07-02 1999-07-02 Knoglecement med antimikrobielle peptider DK1091774T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98202233 1998-07-02
PCT/NL1999/000417 WO2000001427A1 (fr) 1998-07-02 1999-07-02 Ciment a base d'os, contenant des peptides antimicrobiens

Publications (1)

Publication Number Publication Date
DK1091774T3 true DK1091774T3 (da) 2003-02-24

Family

ID=8233884

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99931589T DK1091774T3 (da) 1998-07-02 1999-07-02 Knoglecement med antimikrobielle peptider

Country Status (10)

Country Link
EP (1) EP1091774B1 (fr)
JP (1) JP2002519155A (fr)
AT (1) ATE226836T1 (fr)
AU (1) AU762262B2 (fr)
CA (1) CA2336030A1 (fr)
DE (1) DE69903732T2 (fr)
DK (1) DK1091774T3 (fr)
ES (1) ES2186377T3 (fr)
PT (1) PT1091774E (fr)
WO (1) WO2000001427A1 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1228772A1 (fr) * 2001-02-01 2002-08-07 AM-Pharma B.V. Nouveau ciment osseux contenant des principes actifs
US6811777B2 (en) 2002-04-13 2004-11-02 Allan Mishra Compositions and minimally invasive methods for treating incomplete connective tissue repair
US7608258B2 (en) 2002-04-13 2009-10-27 Allan Mishra Method for treatment of tendinosis using platelet rich plasma
WO2005065242A2 (fr) 2003-12-29 2005-07-21 Am Biosolutions Methode de traitement du cancer au moyen du produit de liberation des plaquettes sanguines
US7462268B2 (en) 2004-08-20 2008-12-09 Allan Mishra Particle/cell separation device and compositions
US8227406B2 (en) 2006-05-16 2012-07-24 Dermagen Ab Antimicrobial peptides
WO2010042658A1 (fr) 2008-10-07 2010-04-15 Bioparadox, Llc Utilisation d’une composition de plasma riche en plaquettes dans le traitement d’anomalies de conduction cardiaque
JP2012180302A (ja) * 2011-03-01 2012-09-20 Tokai Univ 抗グラム陰性菌剤
WO2014144004A1 (fr) 2013-03-15 2014-09-18 The Board Of Trustees Of The University Of Arkansas Peptides ayant une activité antifongique et procédés d'utilisation des peptides
US20140356893A1 (en) 2013-06-04 2014-12-04 Allan Mishra Compositions and methods for using platelet-rich plasma for drug discovery, cell nuclear reprogramming, proliferation or differentiation

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5294605A (en) * 1990-07-19 1994-03-15 The Scripps Research Institute Amphiphilic peptide compositions and analogues thereof
DK0510912T3 (da) * 1991-04-24 1998-02-09 Morinaga Milk Industry Co Ltd Antimikrobielt peptid og antimikrobielt middel
US5270300A (en) * 1991-09-06 1993-12-14 Robert Francis Shaw Methods and compositions for the treatment and repair of defects or lesions in cartilage or bone
CA2151486A1 (fr) * 1993-01-12 1994-07-21 Arthur J. Ammann Formulation tgf-beta pour induire la croissance osseuse
US5522893A (en) * 1993-03-12 1996-06-04 American Dental Association Health Foundation Calcium phosphate hydroxyapatite precursor and methods for making and using the same
AU723740B2 (en) * 1995-06-06 2000-09-07 Howmedica Inc. Biocompatible hydroxyapatite formulations and uses therefor
US5994306A (en) * 1995-11-22 1999-11-30 Intrabiotics Pharmaceuticals, Inc. Fine-tuned protegrins
NL1008139C2 (nl) * 1998-01-27 1999-07-28 Stichting Tech Wetenschapp Antimicrobiële peptiden.
JPH11310540A (ja) * 1998-04-28 1999-11-09 Nippon Electric Glass Co Ltd 薬物徐放材料

Also Published As

Publication number Publication date
DE69903732T2 (de) 2003-07-03
ES2186377T3 (es) 2003-05-01
JP2002519155A (ja) 2002-07-02
WO2000001427A1 (fr) 2000-01-13
EP1091774A1 (fr) 2001-04-18
AU762262B2 (en) 2003-06-19
CA2336030A1 (fr) 2000-01-13
AU4804099A (en) 2000-01-24
DE69903732D1 (de) 2002-12-05
ATE226836T1 (de) 2002-11-15
EP1091774B1 (fr) 2002-10-30
PT1091774E (pt) 2003-03-31

Similar Documents

Publication Publication Date Title
DE69835279D1 (de) Zusammensetzungen und verfahren zur behandlung von infektionen unter verwendung von kationischen peptiden allein oder in kombination mit antibiotika
HUP0004381A1 (en) Method for microbial production of amino acids of the aspartate and/or glutamate family and agents which can be used in said method
GR3019901T3 (en) Osteoinductive pharmaceutical formulations
DE59911344D1 (de) Verfahren zur Herstellung von Methylendi (phenylamin) und Methylendi (phenylisocyanat)
DE59801864D1 (de) Verfahren zur elektrischen steuerung und regelung der bewegung von elektrisch betriebenen aggregaten
DE69835103D1 (de) Zusammensetzung zur behandlung von atemwegs- und hauterkrankungen mit mindestens einem leukotrienantagonist und mindestens einem antihistaminikum
PT946190E (pt) Metodos e composicoes para estimular o crescimento de neurites
PL344589A1 (en) COMPOSITION COMPRISING β-HYDROXY-β-METHYLBUTYRIC ACID AND AT LEAST ONE AMINO ACID AND METHODS OF USE
DE69922819D1 (de) Methode zur prävention und behandlung von dehnungsstreifen (striae distensae) und deren verwendung in dermatologie
DK1091774T3 (da) Knoglecement med antimikrobielle peptider
DE69800768D1 (de) Verfahren zur Beendigung des Nachhärtens von Silikonelastomeren mit Aminosäureestern
DE69613063D1 (de) Zusammensetzungen und Verfahren zur Wirkungsverstärkung von Antibiotika mit Polyphenolen
DE69812784D1 (de) Zusammensetzung zur Vorbeugung und Beseitigung von Pflanzenkrankheiten
DE60006183D1 (de) Härtungsbeschleuniger und Harzzusammensetzung
HK38193A (en) Heat curing cement composition,method of hardening same,and hardened body formed therefrom
BR9710379A (pt) Material decorativo de tit-nio e m-todo de endurecimento para o mesmo
WO2003063775A3 (fr) Procedes et compositions favorisant la pousse des cheveux a l'aide de peptides de liaison d'actine
DE69808475D1 (de) Aminosäurederivate zur behandlung von schlaganfall
IL133172A (en) Diphosphonic acid salts for the treatment of osteoporosis
DE60126211D1 (de) Zementklinker, zementzusammensetzung, verfahren zur herstellung von zementklinker und verfahren zur behandlung von alkalihaltigen abfällen
ATE353859T1 (de) Beschleunigerzusammensetzung zur beschleunigung des erstarrens und/oder erhärtens einer zementzusammensetzung
GB9929497D0 (en) Improved amino acid mixtures for the treatment and/or management of certain diseases
DE59901672D1 (de) Verfahren zur präparation von knochenmaterial
DE69738985D1 (de) Raffinosesynthetase gen, verfahren zur herstellung von raffinose und transformierte pflanze
BR9708712A (pt) Processo para a preparação de uma resina avançada e composição curada